Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA)
Atsushi Tanaka(Friends United), Mizuki Yamaguchi, Takeshi Tobiume(Tokushima University), Tomomi Matsuura(Keio University), Yoshinori Takiguchi, Kenya Kusunose(University of the Ryukyus), Ayumu Yajima(Saga University), Hisako Yoshida(Saga University), Kiriko Watanabe, Kohei Kaneta, Y Kawabata, Takayuki Ise(Tokushima University Hospital), Junichiro James Kazama(Japanese Society for Dialysis Therapy), Toshiaki Kadokami(Fukui-ken Saiseikai Hospital), Muneyuki Kadota, Hayato Tanabe, Koichi Node(Saga University), Masahiro Sato, Aya Shiraki, Ken Onizuka, T Takahashi(Hyogo Prefectural Cancer Center), Yuki Hotta, Kumiko Suto, Goro Yoshioka(Saga University), Takeshi Soeki(Tokushima University), Junichiro Nishi, Itaru Hisauchi(Dokkyo Medical University Saitama Medical Center), Masataka Sata(Tokushima University), Mariko Iwasaki, Ryo Nakamura(City Of Hope National Medical Center), Kohei Kamishita(Social Insurance Saitama Chuo Hospital), Yuichiro Okushi(Cleveland Clinic), Hiroshi Hongo(Saga University), Michio Shimabukuro(Fukushima Medical University), Masahiro Natsuaki(Saga University), Koji Yamaguchi(University of Occupational and Environmental Health Japan), Tetsuya Kaneko, Yu Saito, Tetsuya Ishikawa(Saitama Prefecture), Isao Taguchi(Dokkyo Medical University Saitama Medical Center), K. Yokoi(Saga University), Shusuke Yagi(Shikoku Central Hospital of the Mutual Aid Association of Public School Teachers), Kazuhisa Matsumoto, Hirotsugu Yamada(Tokushima University Hospital), Motoko Tago(Saga University), Tetsuzo Wakatsuki(Tokushima University), Shinjo Sonoda(University of Occupational and Environmental Health Japan), Hiromitsu Seno, Machiko Asaka
Cited by 22
Related Papers
Distinct Metabolic Flow Enables Large-Scale Purification of Mouse and Human Pluripotent Stem Cell-Derived Cardiomyocytes
|Cell stem cell|2012|1.1k
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease
|Circulation Journal|2020|353